bf/NASDAQ:LTRN_icon.png

NASDAQ:LTRN

Lantern Pharma Inc

  • Stock

USD

Last Close

3.36

06/11 21:00

Market Cap

44.43M

Beta: 0.64

Volume Today

16.49K

Avg: 24.91K

PE Ratio

−3.14

PFCF: −3.29

OverviewFinancialsAPI

    Description

    Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a combination therapy for no...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.6-0.5-0.4-0.3-0.2-0.12019-03-302020-03-312022-03-102024-03-182024-11-06

    Revenue (Estimate*)

    0.000.000.010.010.012019-03-302020-03-312022-03-102024-03-182024-11-06

    *Estimate based on analyst consensus